¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22
±³À°ÀÏÀÚ : 2024-06-22
±³À°Àå¼Ò : ¼­¿ïµå·¹°ï½ÃƼȣÅÚ(ÇѶóA,B,C·ë)

±³À°ÁÖÁ¦ : 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷

ÁÖÃÖ±â°ü : ´ëÇѳúÀüÁõÇÐȸ
´ã´çÀÚ : ÀÌ°¡¿¬
¿¬¶ôó : 02-362-9662  

À̸ÞÀÏ : epilepsy@kes.or.kr

±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú, Á¤½Å°Ç°­ÀÇÇаú, ½Å°æ¿Ü°ú, ½Å°æ°ú, ÀÇ»çÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÁ¤Ã¥

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 19 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 200,000¿ø  

ºñ°í [»çÀüµî·Ï] Àü¹®ÀÇ(Á¤È¸¿ø ¹× Á¾½Åȸ¿ø): 100,000¿ø ÁØȸ¿ø(Àü°øÀÇ): 30,000¿ø ºñȸ¿ø : 180,000¿ø ±â»ç,°£È£»ç,¿¬±¸¿ø : ¹«·á [ÇöÀåµî·Ï] Àü¹®ÀÇ(Á¤È¸¿ø ¹× Á¾½Åȸ¿ø) : 120,000¿ø ÁØȸ¿ø(Àü°øÀÇ) : 50,000¿ø ºñȸ¿ø : 200,000¿ø ±â»ç,°£È£»ç,¿¬±¸¿ø : ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 08:30~08:45 Case 1. Diagnosis and treatment of patients resenting with pain as a symptom of epilepsy: navigating the challenges À̵¿¾Æ(ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë ¹éº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 08:45~09:00 Case 2. The expedition to find focality in pharmacoresistant pediatric epilepsy ¾çµ¿È­(°í·ÁÀÇ´ë ±¸·Îº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 09:00~09:15 Understanding pharmacokinetics and drug interactions of antiseizure medications through cases 1 Çã°æ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 09:15~09:30 Understanding pharmacokinetics and drug interactions of antiseizure medications through cases 2 Çã°æ(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

ÈÞ½Ä 06¿ù 22ÀÏ 09:30~09:40 Coffee Break ()

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A+B 09:40~10:30 Presidential symposium. Identification of epileptic network using stereoelectroencephalography Fabrice Bartolomei (Aix-Marseille University)

ÈÞ½Ä 06¿ù 22ÀÏ 10:30~10:40 Coffee Break ()

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 10:40~11:00 Hippocampus and Imagination Á¤¹Îȯ(Çѱ¹°úÇбâ¼ú¿ø(KAIST))

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 11:00~11:20 Uric acid and seizure disorder from bedside to bench ÃÖÁØ¿µ(¾ÆÁÖÀÇ´ë ¾ÆÁִ뺴¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 11:40~12:20 Two-year experience with Zebinix in single tertiary center ±èµ¿¿í(°Ç±¹ÀÇ´ë °Ç±¹´ëº´¿ø)

ÈÞ½Ä 06¿ù 22ÀÏ 12:20~12:30 Coffee Break ()

±âŸ 06¿ù 22ÀÏ 12:30~13:30 Poster presentation ()

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 13:30~13:50 Basic principles and clinical application of MEG in Korea È«½ÂºÀ(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 13:50~14:10 MEG and epilepsy surgery Àå¿ø¼®(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 14:10~14:30 MEG-based brain mapping for epilepsy and other diseases Nobukazu Nakasato (Tohoku University School of Medicine)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 14:30~14:50 Zebrafish EEG predicts the efficacy of antiseizure medications ±è¼ÒÈñ(´ë±¸°æºÏ°úÇбâ¼ú¿ø(DGIST))

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 14:50~15:10 The role of animal models in drug repurposing for developmental and epileptic encephalopathies ±è¹ÎÁö(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 15:10~15:30 Is there a promise of precision medicine using current gene editing therapies for developmental and epileptic encephalopathies °í¾Æ¶ó(¿¬¼¼ÀÇ´ë ¼¼ºê¶õ½ºº´¿ø)

ÈÞ½Ä 06¿ù 22ÀÏ 15:30~15:40 Coffee Break ()

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 15:40~16:00 Incidence of seizures and risk of epilepsy in autoimmune encephalitis ÁÖ°Ç(¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 16:00~16:20 Clinical and electroencephalographic features of epileptic seizures in autoimmune encephalitis ÀÌ¿ìÁø(¼­¿ïÀÇ´ë ºÐ´ç¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 16:20~16:40 Management and long-term outcomes of epileptic seizures in autoimmune encephalitis ¼±¿ìÁØ»ó(¼º±Õ°üÀÇ´ë °­ºÏ»ï¼ºº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 16:40~17:00 Freud and psychogenic non-epileptic seizures David Y. Ko(Loma Linda VA Medical Center)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 17:00~17:20 Electroencephalographic and imaging features of psychogenic non-epileptic seizures ±è¼ºÈÆ(°¡Å縯ÀÇ´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra A 17:20~17:40 Proper management of psychogenic non-epileptic seizures ±è¿ìÁØ(°¡Å縯ÀÇ´ë ¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 08:30~08:45 NCSE in critically ill patients should be treated aggressively ±è¿µ¼ö(°æ»óÀÇ´ë °æ»ó´ëº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 08:45~09:00 NCSE in critically ill patients should NOT be treated aggressively ÀÓ¼ºÃ¶(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 09:00~09:15 Focal-aware SE should be treated aggressively ±è¿µ¼ö(°æ»óÀÇ´ë °æ»ó´ëº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 09:15~09:30 Focal-aware SE should NOT be treated aggressively ÀÓ¼ºÃ¶(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 10:40~11:00 Epilepsy diagnosis and syndromic classification ¹®ÁøÈ­(ÇѾçÀÇ´ë ±¸¸®º´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 11:00~11:20 Seizure intractability and drug response Ji Yeoun Yoo(Icahn School of Medicine at Mount Sinai )

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 11:20~11:40 Cognitive and behavioral consequences À̺¸·Ã(ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 11:40~12:20 Lacosamide as an alternative treatment option in status epilepticus  ÀÌÁöÈÆ(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 13:30~13:50 New landscape of epilepsy surgery: SEEG guided, less invasive surgery and neuromodulation ¼Õ¿µ¹Î(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 13:50~14:10 A Novel Method for Detecting High-Frequency Oscillations with High Specificity Hohyun Cho(Washington University School of Medicine in St. Louis, Missouri, USA)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 14:10~14:30 Usefulness of SEEG in epilepsy surgery: experiences in Nishiniigata Chuo Hospital Masafumi Fukuda (Nishi Niigata Chuo National Hospital)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 14:30~14:50 EPIDIOLEX¢ç (cannabidiol), an FDA-approved drug for Lennox-Gastaut syndrome Yong D. Park(Augusta University )

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 14:50~15:10 Corpus callosotomy and vagus nerve stimulation for Lennox-Gastaut syndrome Joo Hee Seo(AdventHealth for Children)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 15:10~15:30 Deep brain stimulation of thalamic centromedian nucleus for Lennox-Gastaut syndrome Hyunmi Kim(Stanford University)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 15:40~16:00 Challenging clinical situation in refractory status epilepticus: NORSE Ji Yeoun Yoo(Icahn School of Medicine at Mount Sinai )

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 16:00~16:20 Challenging clinical situation in refractory status epilepticus: FIRES °­ÁØ¿ø(Ãæ³²´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 16:20~16:40 Preclinical models of NORSE/FIRES: how and why Sookyong Koh (University of Nebraska )

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 16:40~17:00 Epidemiology of cognitive comorbidities in epilepsy ÃÖ¼±¾Æ(ÀÌÈ­ÀÇ´ë ¸ñµ¿º´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 17:00~17:20 Interictal epileptiform activity and cognitive comorbidities: intracranial EEG study ±è¿ìÁß(¼­¿ïÀÇ´ë ¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra B 17:20~17:40 Deciphering epilepsy-associated comorbidities through hippocampal neurogenesis Á¶°æ¿Á(°¡Å縯ÀÇ´ë ¾à¸®Çб³½Ç)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra C 09:40~11:40 Curry hands-on practice ±¸¿ë¼­(¿ï»êÀÇ´ë ¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra C 13:30~15:30 Epidemiologic Study for Seizure and Epilepsy using Nationwide database for Corean Epilepsy patients (ESSENCE) study group À̼­¿µ(°­¿øÀÇ´ë °­¿ø´ëº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ Hanra C 15:40~17:40 consideration for clinical cde deployment: clinical use vs. research application ¼Õ¿µ¹Î(¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѳúÀüÁõÇÐȸ 29rd KOREAN EPILEPSY CONGRESS (2024 KEC) 2ÀÏÂ÷ : 2024-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2024³â ¼­´ë¹®±¸ÀÇ»çȸ ¿Â¶óÀÎÇмú´ëȸ : 2024-06-22
´ÙÀ½±Û 2024³â Á¦ 23ȸ ´ëÇѵΰ³¾È¸é¼ºÇü¿Ü°úÇÐȸ Ãá°è½ÉÆ÷Áö¾ö : 2024-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 690 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 737 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,109 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,062 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 985 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,392 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,425 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷